Cargando…
Anakinra Therapy for Non-cancer Inflammatory Diseases
Interleukin-1 (IL-1) is the prototypical inflammatory cytokine: two distinct ligands (IL-1α and IL-1β) bind the IL-1 type 1 receptor (IL-1R1) and induce a myriad of secondary inflammatory mediators, including prostaglandins, cytokines, and chemokines. IL-1α is constitutively present in endothelial a...
Autores principales: | Cavalli, Giulio, Dinarello, Charles A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232613/ https://www.ncbi.nlm.nih.gov/pubmed/30459597 http://dx.doi.org/10.3389/fphar.2018.01157 |
Ejemplares similares
-
Corrigendum: Anakinra Therapy for Non-cancer Inflammatory Diseases
por: Cavalli, Giulio, et al.
Publicado: (2019) -
Continuous IV infusion of anakinra
por: Saunders, Brittney N., et al.
Publicado: (2023) -
Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response
por: Vitale, Antonio, et al.
Publicado: (2019) -
Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020) -
Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)